Journal of Neuroscience, Vol 11, 3520-3530, Copyright © 1991 by Society for Neuroscience
Isolation of the progenitor cells of the sympathoadrenal lineage from embryonic sympathetic ganglia with the SA monoclonal antibodies
JF Carnahan and PH Patterson
Biology Division, California Institute of Technology, Pasadena 91125.
Our previous articles in this series described the production of five
monoclonal antibodies (SA1-5) that bind to adrenal chromaffin cells and to
cells in embryonic sympathetic ganglia and adrenal primordia (Carnahan and
Patterson, 1991), and the downregulation of the sympathoadrenal (SA)
antigens in vivo as neuronal markers begin to be expressed (Anderson et
al., 1991). These results support the hypothesis that sympathetic neurons
and adrenal chromaffin cells are derived from a common embryonic progenitor
that displays both neuron- and chromaffin cell-specific markers. We have
taken advantage of the fact that at least some of the SA antigens are
expressed on the cell surface to isolate SA+ cells from embryonic day 14.5
rat superior cervical, sympathetic ganglia by fluorescence-activated cell
sorting. This population of cells is significantly enriched in the
expression of markers (tyrosine hydroxylase and neurofilament) found in the
putative progenitors in situ. Growth in glucocorticoid maintains the
expression of the SA antigens in the sorted cells and induces the
chromaffin cell marker enzyme phenylethanolamine N-methyl transferase. In
contrast, growth of the sorted cells in basic fibroblast growth factor,
NGF, and insulin results in the rapid loss of SA 1 expression and the
outgrowth of neurites. The ability to manipulate the fate of the SA+ cells
in vitro confirms the suggestion from the in vivo observations that the SA+
cells in the ganglia are at least bipotential progenitors, capable of
differentiating along the chromaffin or neuronal pathways.